Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Renal Failure Impact on the Outcomes of ST-Segment Elevation Myocardial Infarction Patients Due to a Left Main Coronary Culprit Lesion Treated Using a Primary Percutaneous Coronary Intervention.

Homorodean C, Iancu AC, Dregoesc IM, Spînu M, Ober MC, Tãtaru D, Leucuţa D, Olinic M, Olinic DM.

J Clin Med. 2019 Apr 25;8(4). pii: E565. doi: 10.3390/jcm8040565.

2.

Halve the dose while maintaining image quality in paediatric Cone Beam CT.

Oenning AC, Pauwels R, Stratis A, De Faria Vasconcelos K, Tijskens E, De Grauwe A, Jacobs R, Salmon B; Dimitra research group.

Sci Rep. 2019 Apr 2;9(1):5521. doi: 10.1038/s41598-019-41949-w.

3.

Prognostic Factors after Percutaneous Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma. Impact of Incomplete Ablation on Recurrence and Overall Survival Rates.

Sparchez Z, Mocan T, Radu P, Mocan LP, Sparchez M, Leucuta DC, Al Hajjar N.

J Gastrointestin Liver Dis. 2018 Dec;27(4):399-407. doi: 10.15403/jgld.2014.1121.274.pro.

4.

Pressure management as an occupational stress risk factor in irritable bowel syndrome: A cross-sectional study.

Popa SL, Leucuta DC, Dumitrascu DL.

Medicine (Baltimore). 2018 Dec;97(49):e13562. doi: 10.1097/MD.0000000000013562.

5.

Gene variants of osteoprotegerin, estrogen-, calcitonin- and vitamin D-receptor genes and serum markers of bone metabolism in patients with Gaucher disease type 1.

Zimmermann A, Popp RA, Rossmann H, Bucerzan S, Nascu I, Leucuta D, Weber MM, Grigorescu-Sido P.

Ther Clin Risk Manag. 2018 Oct 24;14:2069-2080. doi: 10.2147/TCRM.S177480. eCollection 2018.

6.

New safety signals assessed by the Pharmacovigilance Risk Assessment Committee at EU level in 2014-2017.

Farcaş A, Măhălean A, Bulik NB, Leucuta D, Mogoșan C.

Expert Rev Clin Pharmacol. 2018 Oct;11(10):1045-1051. doi: 10.1080/17512433.2018.1526676. Epub 2018 Oct 1.

PMID:
30269618
7.

Determining Factors of Arterial Stiffness in Subjects with Metabolic Syndrome.

Cozma A, Sitar-Taut A, Orăşan O, Leucuta D, Alexescu T, Stan A, Negrean V, Sampelean D, Pop D, Zdrenghea D, Vulturar R, Fodor A.

Metab Syndr Relat Disord. 2018 Nov;16(9):490-496. doi: 10.1089/met.2018.0057. Epub 2018 Sep 5.

PMID:
30183523
8.

Immunological markers as predictors of developing steroid-induced diabetes mellitus in pemphigus vulgaris patients: An observational study.

Dănescu AS, Bâldea I, Leucuţa DC, Lupan I, Samaşca G, Sitaru C, Chiorean R, Baican A.

Medicine (Baltimore). 2018 Apr;97(17):e0463. doi: 10.1097/MD.0000000000010463.

9.

High-resolution ultrasonography in assessing temporomandibular joint disc position.

Talmaceanu D, Lenghel LM, Bolog N, Popa Stanila R, Buduru S, Leucuta DC, Rotar H, Baciut M, Baciut G.

Med Ultrason. 2018 Feb 4;1(1):64-70. doi: 10.11152/mu-1025.

10.

The importance of a multidisciplinary team in rectal cancer management.

Bochis OV, Fekete Z, Vlad C, Fetica B, Leucuta DC, Busuioc CI, Irimie A.

Clujul Med. 2017;90(3):279-285. doi: 10.15386/cjmed-689. Epub 2017 Jul 15.

11.

A Lyme borreliosis diagnosis probability score - no relation with antibiotic treatment response.

Briciu VT, Flonta M, Leucuţa D, Cârstina D, Ţăţulescu DF, Lupşe M.

Infect Dis (Lond). 2017 May;49(5):373-379. doi: 10.1080/23744235.2016.1272134. Epub 2017 Jan 3.

PMID:
28049383
12.

Molecular markers in the diagnosis of invasive pituitary adenomas - an immunohistochemistry study.

Moldovan IM, Şuşman S, Pîrlog R, Jianu EM, Leucuţa DC, Melincovici CS, Crişan D, Florian IŞ.

Rom J Morphol Embryol. 2017;58(4):1357-1364.

13.

Keratinocyte growth factor and its receptor expression in chronic otitis media with and without cholesteatoma.

Harabagiu OE, Cosgarea M, Mogoantă CA, Leucuţa DC, Maniu AA.

Rom J Morphol Embryol. 2017;58(4):1333-1338.

14.

Impaired pressure management in the Irritable Bowel Syndrome.

Popa SL, Brate AT, Leucuta DC, Baban A.

J Gastrointestin Liver Dis. 2016 Dec;25(4):566-567. doi: 15403/jgld.2014.1121.254.bow. No abstract available.

PMID:
27981317
15.

Cholelithiasis in Patients with Gaucher Disease type 1: Risk Factors and the Role of ABCG5/ABCG8 Gene Variants.

Zimmermann A, Popp RA, Al-Khzouz C, Bucerzan S, Naşcu I, Leucuta D, Galle PR, Grigorescu-Sido P.

J Gastrointestin Liver Dis. 2016 Dec;25(4):447-455. doi: 10.15403/jgld.2014.1121.254.zim.

16.

Combined use of renin-angiotensin-aldosterone system-acting agents: a cross-sectional study.

Farcas A, Leucuta D, Bucsa C, Mogosan C, Dumitrascu D.

Int J Clin Pharm. 2016 Dec;38(6):1390-1397. Epub 2016 Sep 27.

PMID:
27677980
17.

Paraoxonase-1 activities in children and adolescents with type 1 diabetes mellitus.

Craciun EC, Leucuta DC, Rusu RL, David BA, Cret V, Dronca E.

Acta Biochim Pol. 2016;63(3):511-5. doi: 10.18388/abp.2015_1209. Epub 2016 Jun 23.

18.

Immunohistochemistry and real-time PCR as diagnostic tools for detection of Borrelia burgdorferi sensu lato in ticks collected from humans.

Briciu VT, Sebah D, Coroiu G, Lupşe M, Cârstina D, Ţăţulescu DF, Mihalca AD, Gherman CM, Leucuţa D, Meyer F, Hizo-Teufel C, Fingerle V, Huber I.

Exp Appl Acarol. 2016 May;69(1):49-60. doi: 10.1007/s10493-016-0012-y. Epub 2016 Jan 22.

PMID:
26801157
19.

Prediction of survival for patients with pemphigus vulgaris and pemphigus foliaceus: a retrospective cohort study.

Baican A, Chiorean R, Leucuta DC, Baican C, Danescu S, Ciuce D, Sitaru C.

Orphanet J Rare Dis. 2015 Apr 22;10:48. doi: 10.1186/s13023-015-0263-4.

20.

Quantitative expression of serum biomarkers involved in angiogenesis and inflammation, in patients with glioblastoma multiforme: correlations with clinical data.

Chiorean R, Berindan-Neagoe I, Braicu C, Florian IS, Leucuta D, Crisan D, Cernea V.

Cancer Biomark. 2014;14(2-3):185-94. doi: 10.3233/CBM-130310.

PMID:
24878820

Supplemental Content

Loading ...
Support Center